Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.

Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2019 06 01; 84(6):1157-1168.

View in: PubMed

subject areas

Aged
Combined Modality Therapy
Female
Fibrinolytic Agents
Hematoma
Humans
Intracranial Hemorrhages
Male
Middle Aged
Minimally Invasive Surgical Procedures
Recovery of Function
Tissue Plasminogen Activator
Treatment Outcome

authors with profiles

Issam Awad
Romuald Girard
Sean Polster